Glucagon-like peptide-1 (GLP-1) is a gut incretin hormone and is currently considered an attractive agent for the treatment of type 2 diabetes
TripleHormone-Receptor Agonist Reta for ObesityA Phase 2 Trial
Consistently, NAC and cysteine have also been shown to enhance Cu 2+ reduction and copper-induced proteotoxic stress, 168 suggesting that thiol-rich reducing environments can, under specific conditions, contribute to cytotoxicity
doi: 10.1038/s41467-019-13637-w 56 MickleADWonSMNohKNYoonJMeachamKWXueYet al
Physical and Chemical Stability As always, you should review reference books, peer-reviewed literature and commercially available product information to provide information on factors that may affect the potency of the compounded formulation
Clinical trials show significant weight regain within 12 months of stopping GLP-1 therapy